2021 annual financial data
SAB Biotherapeutics, Inc. 2021 Net margin
SAB Biotherapeutics, Inc. 2021 net margin with verified reported values.
Direct answer
Net margin was -28.16%.
Operating income was -13,393,000 USD and net income was -17,145,000 USD.
Operating cash flow was 1,986,873 USD.
Get free SAB Biotherapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 60,876,000 USD
- Operating income
- -13,393,000 USD
- Net income
- -17,145,000 USD
- Operating cash flow
- 1,986,873 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all SAB Biotherapeutics, Inc. financial years